Charles S. Parham

1.0k total citations
24 papers, 875 citations indexed

About

Charles S. Parham is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Charles S. Parham has authored 24 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Charles S. Parham's work include Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Arrest and Resuscitation (6 papers). Charles S. Parham is often cited by papers focused on Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Arrest and Resuscitation (6 papers). Charles S. Parham collaborates with scholars based in United States, Malaysia and Sweden. Charles S. Parham's co-authors include Gary J. Grover, Steven Dzwonczyk, Paul G. Sleph, G. J. Grover, Raymond B. Darbenzio, Suzanne Moreland, Diane M. McMullen, Diane E. Normandin, Albert J. DʼAlonzo and A J D'Alonzo and has published in prestigious journals such as Circulation Research, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

Charles S. Parham

24 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles S. Parham United States	13	461	293	259	241	191	24	875
Jun‐ichi Imagawa Japan	12	283 0.6×	124 0.4×	140 0.5×	62 0.3×	158 0.8×	35	625
R.E. London United States	9	294 0.6×	209 0.7×	118 0.5×	20 0.1×	296 1.5×	13	754
Helen Maddock United Kingdom	15	252 0.5×	291 1.0×	115 0.4×	26 0.1×	287 1.5×	53	790
M Tani Japan	11	662 1.4×	588 2.0×	252 1.0×	11 0.0×	362 1.9×	23	1.0k
Giuliano Dodoni Italy	8	182 0.4×	105 0.4×	83 0.3×	28 0.1×	341 1.8×	8	497
Elias Bofilis Greece	10	234 0.5×	78 0.3×	143 0.6×	26 0.1×	62 0.3×	14	347
Annette Hambrock Germany	13	386 0.8×	96 0.3×	143 0.6×	9 0.0×	258 1.4×	22	584
H. Miyata Japan	8	283 0.6×	294 1.0×	48 0.2×	14 0.1×	529 2.8×	14	802
Joseph J. Sikora United States	13	123 0.3×	96 0.3×	42 0.2×	38 0.2×	148 0.8×	25	640
Simone Bonoron‐Adèle France	14	181 0.4×	433 1.5×	58 0.2×	9 0.0×	236 1.2×	22	763

Countries citing papers authored by Charles S. Parham

Since Specialization

Citations

This map shows the geographic impact of Charles S. Parham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Parham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Parham more than expected).

Fields of papers citing papers by Charles S. Parham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Parham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Parham. The network helps show where Charles S. Parham may publish in the future.

Co-authorship network of co-authors of Charles S. Parham

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Parham. A scholar is included among the top collaborators of Charles S. Parham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Parham. Charles S. Parham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grover, Gary J., et al.. (2003). Protective Effect of Mitochondrial KATP Activation in an Isolated Gracilis Model of Ischemia and Reperfusion in Dogs. Journal of Cardiovascular Pharmacology. 42(6). 790–792. 18 indexed citations

Grover, Gary J., Albert J. DʼAlonzo, Raymond B. Darbenzio, et al.. (2002). In Vivo Characterization of the Mitochondrial Selective KATP Opener (3 R)-trans-4-((4-Chlorophenyl)-N-(1 H-imidazol-2-ylmethyl)dimethyl-2 H-1-benzopyran-6-carbonitril Monohydrochloride (BMS-191095): Cardioprotective, Hemodynamic, and Electrophysiological Effects. Journal of Pharmacology and Experimental Therapeutics. 303(1). 132–140. 26 indexed citations

Grover, Gary J., Charles S. Parham, Daisy B. Whigan, & James Mitroka. (1996). BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 380–387. 5 indexed citations

Grover, Gary J., Steven Dzwonczyk, Diane M. McMullen, et al.. (1995). Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946. Journal of Cardiovascular Pharmacology. 26(2). 289–294. 237 indexed citations

Grover, Gary J., et al.. (1995). Protective Effect of the Serotonin Receptor Antagonist Cinanserin in Two Canine Models of Pacing-Induced Myocardial Ischemia. Pharmacology. 50(5). 286–297. 5 indexed citations

Grover, Gary J., Albert J. DʼAlonzo, Charles S. Parham, & Raymond B. Darbenzio. (1995). Cardioprotection with the KATP Opener Cromakalim Is Not Correlated with Ischemic Myocardial Action Potential Duration. Journal of Cardiovascular Pharmacology. 26(1). 145–152. 114 indexed citations

Grover, G. J., Steven Dzwonczyk, & Charles S. Parham. (1993). The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovascular Research. 27(9). 1613–1618. 125 indexed citations

D'Alonzo, A J, Raymond B. Darbenzio, Charles S. Parham, & G. J. Grover. (1992). Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovascular Research. 26(11). 1046–1053. 47 indexed citations

Grover, G. J., Charles S. Parham, & William A. Schumacher. (1991). The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin. Basic Research in Cardiology. 86(2). 99–106. 15 indexed citations

10.

Grover, Gary J., Charles S. Parham, & William A. Schumacher. (1991). The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator. American Heart Journal. 121(2). 426–433. 3 indexed citations

11.

Grover, Gary J., Steven Dzwonczyk, Charles S. Parham, & Paul G. Sleph. (1990). The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovascular Drugs and Therapy. 4(2). 465–474. 106 indexed citations

12.

Grover, Gary J., et al.. (1990). Anti-Ischemic Activity of the Novel Benzazepine Calcium Antagonist SQ 31,486. Journal of Cardiovascular Pharmacology. 16(2). 219–227. 15 indexed citations

13.

Grover, Gary J., Paul G. Sleph, & Charles S. Parham. (1990). Nicorandil Improves postischemic Contractile function Independently of Direct Mycardial.Effects. Journal of Cardiovascular Pharmacology. 15(5). 698–705. 38 indexed citations

14.

Grover, Gary J., Charles S. Parham, Paul G. Sleph, & Suzanne Moreland. (1989). Anti-ischemic and vasorelaxant effects of the new benzazepine calcium channel blocker SQ 31,765.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 1020–1025. 3 indexed citations

15.

Grover, Gary J., Paul G. Sleph, & Charles S. Parham. (1988). The Role of Thromboxane A2 in Reperfusion Injury. Experimental Biology and Medicine. 188(4). 504–508. 14 indexed citations

16.

Grover, Gary J., William A. Schumacher, Michael S. Simon, & Charles S. Parham. (1988). The Effect of the Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist SQ 30,741 on Myocardial Infarct Size and Blood Flow During Myocardial Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology. 12(6). 701–709. 14 indexed citations

17.

Grover, Gary J. & Charles S. Parham. (1987). Effect of Intracoronary Diltiazem on ST-Segment Elevation and Myocardial Blood Flow During Pacing-Induced Ischemia. Journal of Cardiovascular Pharmacology. 10(5). 548–554. 6 indexed citations

18.

Grover, Gary J. & Charles S. Parham. (1987). The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemia. European Journal of Pharmacology. 143(1). 109–117. 5 indexed citations

19.

Saini, R. K., et al.. (1986). Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 237(1). 1–8. 2 indexed citations

20.

Evans, Dale B., Charles S. Parham, & Robert J. Laffan. (1979). Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 240(2). 240–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact